$AGPU Cashflow Statement | Understand Stock

$AGPU

$8.98 +$0.99 (12.39%) Close

$AGPU Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flow from continuing operating activities:
Net loss
Less: loss from discontinued operations
Net loss from continuing operations
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of operating lease right-of-use assets
Write off of aged accounts payable and accrued expenses
Vesting expense
Common stock issued for consulting and other
Amortization of debt discount
Gain on valuation of equity-linked instruments
Gain on valuation of equity-linked instruments and derivative liability
Benefit from release of valuation allowance
Gain on note receivable associated with asset purchase agreement
Gain on extinguishment of PPP loan
Debt extinguishment costs
Loss on impairment of finite-lived intangible assets
Loss on impairment of software acquired
Loss on impairment of property and equipment
Loss on property and equipment disposal
Shares of common stock issued to employees and nonemployees
(Gain) loss on derivative instruments
(Gain) loss on digital assets
Loss on disposal of property and equipment
Loss on disposal of intangible assets

Changes in assets and liabilities:
Accounts receivable
Inventories
Prepaid expense and other assets
Accounts payable
Accrued expenses and other
Contract liabilities
Net cash used in operating activities:
Operating lease liability
Other long-term liabilities
Net cash used in continuing operating activities:
Cash flow from continuing investing activities:
Acquisition of zPREDICTA, net of cash acquired
Crypto assets purchased
Purchase of property and equipment
Proceeds from sale of fixed assets
Acquisition of intangibles
Loan activities
Net cash used in investing activities
Net cash used in continuing investing activities:

Cash flow from continuing financing activities:
Proceeds from issuance of common stock and warrants
Proceeds from exercise of warrants into common stock
Proceeds from debt issuance
Repayment of debt
Payment penalties
Proceeds from issuance of common stock pursuant to equity line
Issuance of common stock, prefunded warrants, warrants and exchange of warrants, net
Costs to issue common stock and warrants
Repurchase of common stock upon vesting of restricted stock units
Other liabilities
Proceeds from issuance of financing note payable
Repayment of note payable
Net cash provided by financing activities
Payments for taxes related to net share settlement of restricted stock units
Net cash provided by continuing financing activities

Discontinued operations:
Net cash used in operating activities
Net cash provided by investing activities
Net cash provided by (used in) financing activities
Net cash provided by (used in) discontinued operations
Net increase (decrease) in cash
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Cash and cash equivalents from continuing operations at beginning of period
Cash and cash equivalents from discontinued operations at beginning of period
Less: Cash from discontinued operations at end of period
Cash and cash equivalents from continuing operations at end of period
Supplemental disclosure for cash flow information:
Cash payments for interest
Adjustment to goodwill for acquisition of zPREDICTA contract liabilities
Equipment transferred from discontinued operations
Right-of-use assets obtained in exchange for lease liabilities
Series F Preferred Stock dividend
Non-cash transactions:
Debt Conversion, Converted Instrument, Amount
Warrants issued pursuant to debt issuance
Shares issued pursuant to CEO note conversion and accrued interest and exchange agreement (in shares)
Shares issued pursuant to former CEO per agreement related to accrued interest
Increase to operating lease right of use asset and lease liability due to new and modified leases
Put and conversion derivative from debt issuance and modification
Preferred stock conversions
Inducement shares issued pursuant to convertible debt
Fixed assets acquired for financing arrangements
Adjustment to fair value
Digital assets received pursuant to securities purchase agreements
Digital asset receivable received pursuant to securities purchase agreements
Vested ATH claimed from Locked ATH Receivable at Fair Value
Shares issued for vested restricted stock units, net of shares withheld for taxes
Common stock issued in connection with reverse stock split
Stock Issued for Convertible Debt
Stock Issued for Debt
Restricted Stock Units (RSUs)
Reverse Stock Split
Reverse Stock Split
Total common stock issued in connection with reverse stock split

Fixed assets acquired for notes receivable and common stock
Redemption of Series F Preferred Stock
Equipment transferred from discontinued operations

Comments